{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T19:45:33Z","timestamp":1725651933011},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T00:00:00Z","timestamp":1305590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11883-011-0185-0","type":"journal-article","created":{"date-parts":[[2011,5,16]],"date-time":"2011-05-16T10:24:53Z","timestamp":1305541493000},"page":"314-320","source":"Crossref","is-referenced-by-count":1,"title":["Antithrombotic Management for Transient Ischemic Attack and Ischemic Stroke (Other than Atrial Fibrillation)"],"prefix":"10.1007","volume":"13","author":[{"given":"J. Donald","family":"Easton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,17]]},"reference":[{"key":"185_CR1","doi-asserted-by":"crossref","unstructured":"Easton JD, Saver JL, Albers GW, et al. Definition and Evaluation of Transient Ischemic Attack. A Scientific Statement for Healthcare Professionals From the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke 2009:STROKEAHA.108.192218.","DOI":"10.1161\/STROKEAHA.108.192218"},{"key":"185_CR2","first-page":"194","volume":"48","author":"JP Whisnant","year":"1973","unstructured":"Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973;48:194\u20138.","journal-title":"Mayo Clin Proc"},{"key":"185_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197807132990201","volume":"299","author":"The Canadian Cooperative Study Group","year":"1978","unstructured":"The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299:53\u20139.","journal-title":"N Engl J Med"},{"key":"185_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.STR.13.1.24","volume":"13","author":"A Muuronen","year":"1982","unstructured":"Muuronen A, Kaste M. Outcome of 314 patients with transient ischemic attacks. Stroke. 1982;13:24\u201331.","journal-title":"Stroke"},{"key":"185_CR5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0404.1989.tb03740.x","volume":"79","author":"PS Sorensen","year":"1989","unstructured":"Sorensen PS, Marquardsen J, Pedersen H, Heltberg A, Munck O. Long-term prognosis and quality of life after reversible cerebral ischemic attacks. Acta Neurol Scand. 1989;79:204\u201313.","journal-title":"Acta Neurol Scand"},{"key":"185_CR6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0404.1990.tb01597.x","volume":"82","author":"L Calandre","year":"1990","unstructured":"Calandre L, Bermejo F, Balseiro J. Long-term outcome of TIAs. RINDs and infarctions with minimum residuum. A prospective study in Madrid. Acta Neurol Scand. 1990;82:104\u20138.","journal-title":"Acta Neurol Scand"},{"key":"185_CR7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jnnp.54.9.793","volume":"54","author":"GJ Hankey","year":"1991","unstructured":"Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry. 1991;54:793\u2013802.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"185_CR8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.55.8.640","volume":"55","author":"GJ Hankey","year":"1992","unstructured":"Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neurol Neurosurg Psychiatry. 1992;55:640\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"185_CR9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.7326\/0003-4819-114-7-552","volume":"114","author":"WN Kernan","year":"1991","unstructured":"Kernan WN, Horwitz RI, Brass LM, Viscoli CM, Taylor KJ. A prognostic system for transient ischemia or minor stroke. Ann Intern Med. 1991;114:552\u20137.","journal-title":"Ann Intern Med"},{"key":"185_CR10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","volume":"325","author":"The Dutch TIA Trial Study Group","year":"1991","unstructured":"The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30\u00a0mg vs. 283\u00a0mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 1991;325:1261\u20136.","journal-title":"N Engl J Med"},{"key":"185_CR11","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","volume":"284","author":"SC Johnston","year":"2000","unstructured":"Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901\u20136.","journal-title":"JAMA"},{"key":"185_CR12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/01.WNL.0000152985.32732.EE","volume":"64","author":"PM Rothwell","year":"2005","unstructured":"Rothwell PM, Warlow CP. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology. 2005;64:817\u201320.","journal-title":"Neurology"},{"key":"185_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","volume":"369","author":"SC Johnston","year":"2007","unstructured":"Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283\u201392.","journal-title":"Lancet"},{"key":"185_CR14","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/STROKEAHA.110.578971","volume":"41","author":"MF Giles","year":"2010","unstructured":"Giles MF, Albers GW, Amarenco P, et al. Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke. 2010;41:1907\u201313.","journal-title":"Stroke"},{"key":"185_CR15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S1474-4422(10)70240-4","volume":"9","author":"A Merwick","year":"2010","unstructured":"Merwick A, Albers GW, Amarenco P, et al. Addition of brain and carotid imaging to the ABCD(2) score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol. 2010;9:1060\u20139.","journal-title":"Lancet Neurol"},{"key":"185_CR16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494\u2013502.","journal-title":"N Engl J Med"},{"key":"185_CR17","first-page":"99","volume":"22","author":"HP Adams Jr","year":"1992","unstructured":"Adams Jr HP, Woolson RF, Biller J, Clarke W. Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group. Haemostasis. 1992;22:99\u2013103.","journal-title":"Haemostasis"},{"key":"185_CR18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","volume":"349","author":"International Stroke Trial Collaborative Group","year":"1997","unstructured":"International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349:1569\u201381.","journal-title":"Lancet"},{"key":"185_CR19","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM199512143332402","volume":"333","author":"R Kay","year":"1995","unstructured":"Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med. 1995;333:1588\u201393.","journal-title":"N Engl J Med"},{"key":"185_CR20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","volume":"6","author":"J Kennedy","year":"2007","unstructured":"\u2022\u2022 Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. The Lancet Neurology 2007;6:961\u20139. The FASTER pilot trial suggests a cerebrovascular population that may benefit from dual antiplatelet treatment without unacceptable hemorrhage.","journal-title":"Lancet Neurol"},{"key":"185_CR21","doi-asserted-by":"crossref","unstructured":"Poisson S, Johnston SC: Prevention of Stroke Following Transient Ischemic Attack. Curr Atheroscler Rep 2011 (in press).","DOI":"10.1007\/s11883-011-0181-4"},{"key":"185_CR22","unstructured":"Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events (CHANCE). ClinicalTrialsgov Identifier: NCT00979589 2011."},{"key":"185_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71\u201386.","journal-title":"BMJ"},{"key":"185_CR24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329\u201339.","journal-title":"Lancet"},{"issue":"suppl","key":"185_CR25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0022-510X(97)90039-3","volume":"151","author":"HC Diener","year":"1997","unstructured":"Diener HC, Forbes C, Riekkinen PJ, Sivenius J, Smets P, Lowenthal A. european stroke prevention study 2: efficacy and safety data. J Neurol Sci. 1997;151(suppl):S1\u2013S77.","journal-title":"J Neurol Sci"},{"key":"185_CR26","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","volume":"367","author":"The ESPRIT Study Group","year":"2006","unstructured":"The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665\u201373.","journal-title":"Lancet"},{"key":"185_CR27","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","volume":"359","author":"RL Sacco","year":"2008","unstructured":"Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238\u201351.","journal-title":"N Engl J Med"},{"key":"185_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000076962","volume":"17","author":"HC Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM, et al. Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data. Cerebrovasc Dis. 2004;17:253\u201361.","journal-title":"Cerebrovasc Dis"},{"key":"185_CR29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","volume":"42","author":"KL Furie","year":"2011","unstructured":"Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42:227\u201376.","journal-title":"Stroke"},{"key":"185_CR30","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001\u201315.","journal-title":"N Engl J Med"},{"key":"185_CR31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045\u201357.","journal-title":"N Engl J Med"},{"key":"185_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/jscd.2000.7216","volume":"9","author":"F Gotoh","year":"2009","unstructured":"Gotoh F, Tohgi H, Hirai S, et al. Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis. 2009;9:147\u201357.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"185_CR33","doi-asserted-by":"crossref","unstructured":"Shinohara Y, Katayama Y, Uchiyama S, et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol. 9:959\u201368.","DOI":"10.1016\/S1474-4422(10)70198-8"},{"key":"185_CR34","unstructured":"Secondary Prevention of Small Subcortical Strokes Trial (SPS3). ClinicalTrialsgov Identifier: NCT00059306 2011."},{"key":"185_CR35","unstructured":"FDA Drug Safety Communication: reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. 2010. (Accessed at http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm203888.htm .)"},{"key":"185_CR36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/CIR.0b013e3181ee08ed","volume":"122","author":"DR Holmes Jr","year":"2010","unstructured":"Holmes Jr DR, Dehmer GJ, Kaul S, Leifer D, O\u2019Gara PT, Stein CM. ACCF\/AHA clopidogrel clinical alert: approaches to the FDA \u201cboxed warning\u201d: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Circulation. 2010;122:537\u201357.","journal-title":"Circulation"},{"key":"185_CR37","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","volume":"304","author":"JL Mega","year":"2010","unstructured":"Mega JL, Simon T, Collet JP, et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010;304:1821\u201330.","journal-title":"JAMA"},{"key":"185_CR38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-153-6-201009210-00005","volume":"153","author":"M Charlot","year":"2010","unstructured":"Charlot M, Ahlehoff O, Norgaard ML, et al. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med. 2010;153:378\u201386.","journal-title":"Ann Intern Med"},{"key":"185_CR39","unstructured":"CLOSURE I: No overall benefit, no reduction in stroke or TIA with PFO closure. 2010. (Accessed January 1, 2011, at http:\/\/www.theheart.org\/article\/1149945.do .)"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-011-0185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-011-0185-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-011-0185-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T20:18:46Z","timestamp":1560197926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-011-0185-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,17]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1007\/s11883-011-0185-0","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,17]]}}}